Cortical sources of resting state EEG rhythms are sensitive to the progression of early stage Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 34, Issue 4, 2013, Pages 1015-1035

  Babiloni, Claudio ^a,b   Lizio, Roberta ^b   Del Percio, Claudio ^b   Marzano, Nicola ^c   Soricelli, Andrea ^c,d   Salvatore, Elena ^e   Ferri, Raffaele ^f   Cosentino, Filomena I I ^f   Tedeschi, Gioacchino ^e   Montella, Patrizia ^e   Marino, Silvia ^g   De Salvo, Simona ^h   Rodriguez, Guido ^h   Nobili, Flavio ^h   Vernieri, Fabrizio ⁱ   Ursini, Francesca ⁱ   Mundi, Ciro ^j   Richardson, Jill C ^k   Frisoni, Giovanni B ^l   Rossini, Paolo M ^b,m  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS SAN RAFFAELE PISANA   (Italy)

^c IRCCS SDN   (Italy)

^d UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^f OASI RESEARCH INSTITUTE IRCCS   (Italy)

^g IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^h UNIVERSITY OF GENOA   (Italy)

ⁱ UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^j Hospital of Foggia   (Italy)

^k GLAXOSMITHKLINE   (United Kingdom)

^l IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^m CATHOLIC UNIVERSITY   (Italy)

more..

Author keywords

Alzheimer's disease; disease progression; electroencephalography; low resolution brain electromagnetic tomography (LORETA)

Indexed keywords

CHOLINESTERASE INHIBITOR;

ADULT; AGED; ALPHA RHYTHM; ALZHEIMER DISEASE; ARTICLE; BETA RHYTHM; COMPARATIVE STUDY; CONTROLLED STUDY; DELTA RHYTHM; DISEASE COURSE; ELECTROCORTICOGRAPHY; ELECTROENCEPHALOGRAM; FEMALE; FOLLOW UP; GAMMA RADIATION; GAMMA RHYTHM; HUMAN; LOW RESOLUTION BRAIN ELECTROMAGNETIC TOMOGRAPHY; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; THETA RHYTHM;

EID: 84876388678     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-121750     Document Type: Article

References (116)

1. Lanctot KL, Herrmann N, Kenneth KY, Khan LR, Liu BA, Loulou MM, Einarson TR (2003) Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: A metaanalysis. CMAJ 169, 557-564. (Pubitemid 37174596)
2. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger- Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P. (2007) Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria. Lancet Neurol 6, 734-746. (Pubitemid 47058377)
3. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, PhelpsCH(2011) The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 270-279.
4. Jack CR Jr, Bernstein MA, Borowski BJ, Gunter JL, Fox NC, Thompson PM, Schuff N, Krueger G, Killiany RJ, Decarli CS, Dale AM, Carmichael OW, Tosun D, Weiner MW (2010) Alzheimer's Disease Neuroimaging Initiative. Update on the magnetic resonance imaging core of the Alzheimer's disease neuroimaging initiative. Alzheimers Dement 6, 212-220.
5. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 263-269.
6. Sperling R (2011) Potential of functional MRI as a biomarker in early Alzheimer's disease. Neurobiol Aging 32(Suppl 1), S37-S43.
7. Tapiola T, Alafuzoff I, Herukka SK, Parkkinen L, Hartikainen P, Soininen H, Pirttilä T (2009) Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Arch Neurol 66, 382-389.
8. Frisoni GB, Fox NC, Jack CR Jr, Scheltens P, Thompson PM (2010) The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol 6, 67-77.
9. Silbert LC, Quinn JF, Moore MM, Corbridge E, Ball MJ, Murdoch G, Sexton G, Kaye JA (2003) Changes in premorbid brain volume predict Alzheimer's disease pathology. Neurology 61, 487-492. (Pubitemid 37025365)
10. Zarow C, Vinters HV, Ellis WG, Weiner MW, Mungas D, White L, Chui HC (2005) Correlates of hippocampal neuron number in Alzheimer's disease and ischemic vascular dementia. Ann Neurol 57, 896-903. (Pubitemid 40798628)
11. Schuff N (2009) Potential role of high-field MRI for studies in Parkinson's disease. Mov Disord 24(Suppl 2), S684-S690.
12. van de Pol LA, Hensel A, Barkhof F, Gertz HJ, Scheltens P, van der Flier WM (2006) Hippocampal atrophy in Alzheimer disease: Age matters. Neurology 66, 236-238. (Pubitemid 43970161)
13. Jagust W, Reed B, Mungas D, Ellis W, Decarli C (2007) What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia? Neurology 69, 871-877. (Pubitemid 47329586)
14. Minoshima S, Shimizu N (1997) [Genome information database]. Tanpakushitsu Kakusan Koso 42(17 Suppl), 3038-3045.
15. Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergström M, Savitcheva I, Huang GF, Estrada S, Ausén B, Debnath ML, Barletta J, Price JC, Sandell J, Lopresti BJ, Wall A, Koivisto P, Antoni G, Mathis CA, Långström B (2004) Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 55, 306-319. (Pubitemid 38269583)
16. Rowe CC, Ng S, Ackermann U, Gong SJ, Pike K, Savage G, Cowie TF, Dickinson KL, Maruff P, Darby D, Smith C, Woodward M, Merory J, Tochon-Danguy H, O'Keefe G, Klunk WE, Mathis CA, Price JC, Masters CL, Villemagne VL (2007) Imaging beta-amyloid burden in aging and dementia. Neurology 68, 1718-1725. (Pubitemid 46763260)
17. Ikonomovic MD, Klunk WE, Abrahamson EE, Mathis CA, Price JC, Tsopelas ND, Lopresti BJ, Ziolko S, BiW, Paljug WR, Debnath ML, Hope CE, Isanski BA, Hamilton RL, DeKosky ST (2008) Post-mortem correlates of in vivo PiBPET amyloid imaging in a typical case of Alzheimer's disease. Brain 131(Pt 6), 1630-1645. (Pubitemid 351806448)
18. Claus JJ, Strijers RL, Jonkman EJ, Ongerboer deVisserBW, Jonker C,Walstra GJ, Scheltens P, van GoolWA (1999) The diagnostic value of electroencephalography in mild senile Alzheimer's disease. Clin Neurophysiol 110, 825-832. (Pubitemid 29281682)
19. Huang C, Wahlund L, Dierks T, Julin P, Winblad B, Jelic V (2000) Discrimination of Alzheimer's disease and mild cognitive impairment by equivalent EEG sources: A crosssectional and longitudinal study. Clin Neurophysiol 111, 1961-1967.
20. Bennys K, Rondouin G, Vergnes C, Touchon J (2001) Diagnostic value of quantitative EEG in Alzheimer disease. Neurophysiol Clin 31, 153-160. (Pubitemid 32661117)
21. Lehmann C,Koenig T, JelicV, Prichep L, John RE,Wahlund LO, Dodge Y, Dierks T (2007) Application and comparison of classification algorithms for recognition of Alzheimer's disease in electrical brain activity (EEG). J Neurosci Methods 161, 342-350. (Pubitemid 46466939)
22. Bonanni L, Thomas A, Tiraboschi P, Perfetti B, Varanese S, Onofrj M (2008) EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up. Brain 131(Pt 3), 690-705. (Pubitemid 351294714)
23. Ommundsen N, Engedal K, Øksengård AR (2011) Validity of the quantitative EEG statistical pattern recognition method in diagnosing Alzheimer's disease. Dement Geriatr Cogn Disord 31, 195-201.
24. Dierks T, Ihl R, Frolich L, Maurer K (1993) Dementia of the Alzheimer type: Effects on the spontaneous EEG described by dipole sources. Psychiatry Res 50, 151-162. (Pubitemid 23289192)
25. Dierks T, Jelic V, Pascual-Marqui RD, Wahlund LO, Julin P, Linden DEJ, Maurer K, Winblad B, Nordberg A (2000) Spatial pattern of cerebral glucose metabolism (PET) correlates with localization of intracerebral EEGgenerators in Alzheimer's disease. Clin Neurophysiol 111, 1817-1824.
26. Ponomareva NV, Selesneva ND, Jarikov GA (2003) EEG alterations in subjects at high familial risk for Alzheimer's disease. Neuropsychobiology 48, 152-159. (Pubitemid 37340203)
27. Jeong J (2004) EEG dynamics in patients with Alzheimer's disease. Clin Neurophysiol 115, 1490-1505. (Pubitemid 38760295)
28. Wolf H, Jelic V, Gertz HJ, Nordberg A, Julin P,Wahlund LO (2003) A critical discussion of the role of neuroimaging in mild cognitive impairment. Acta Neurol Scand Suppl 179, 52-76.
29. Moretti DV, Babiloni C, Binetti G, Cassetta E, Dal Forno G, Ferreri F, Ferri R, Lanuzza Bartolo, Miniussi C, Nobili F, Rodriguez G, Salinari S, RossiniPM(2004) Individual analysis of EEG frequency and band power in mild Alzheimer's disease. Clin Neurophysiol 115, 299-308. (Pubitemid 38117248)
30. Adeli H, Ghosh-Dastidar S, Dadmehr (2005) Alzheimer's disease: Models of computation and analysis of EEGs. Clin EEG Neurosci 36, 131-140. (Pubitemid 41153680)
31. Prichep LS, John ER, Ferris SH, Reisberg B, Almas M, Alper K, Cancro R (1994) Quantitative EEG correlates of cognitive deterioration in the elderly. Neurobiol Aging 15, 85-90. (Pubitemid 24075015)
32. Koenig T, Prichep L, Dierks T, Hubl D, Wahlund LO, John ER, Jelic V (2005) Decreased EEG synchronization in Alzheimer's disease and mild cognitive impairment. Neurobiol Aging 26, 165-171. (Pubitemid 39610461)
33. van Deursen JA, Vuurman EF, Verhey FR, van Kranen- Mastenbroek VH, Riedel WJ (2008) Increased EEG gamma band activity in Alzheimer's disease and mild cognitive impairment. J Neural Transm 115, 1301-1311.
34. Jelic V, Blomberg M, Dierks T, Basun H, Shigeta M, Julin P, Jensen M, Lannfelt L, Winblad B, Wahlund LO (1998) EEG slowing and cerebrospinal fluid tau levels in patients with cognitive decline. Neuroreport 9, 157-160. (Pubitemid 28046674)
35. Rodriguez G, Nobili F, Rocca G, DeCarli F, Gianelli MV, RosadiniG(1998) Quantitative electroencephalography and regional cerebral blood flow: Discriminant analysis between Alzheimer's patients and healthy controls. Dement Geriatr Cogn Disord 9, 238-274.
36. KlimeschW(1999) EEG alpha and theta oscillations reflect cognitive and memory performance: A review and analysis. Brain Res Rev 29, 169-195. (Pubitemid 29191338)
37. Neubauer AC, Freudenthaler HH (1995) Ultradian rhythms in cognitive performance: No evidence for a 1.5-h rhythm. Biol Psychol 40, 281-298.
38. Babiloni C, Binetti G, Cassarino A, Dal Forno G, Del Percio C, Ferreri F, Ferri R, Frisoni G, Galderisi S, Hirata K, Lanuzza B, Miniussi C, Mucci A, Nobili F, Rodriguez G, Romani GL, Rossini PM (2006) Sources of cortical rhythms in adults during physiological aging: A multi-centric EEG study. Human Brain Mapp 27, 162-172. (Pubitemid 43238488)
39. Babiloni C, Cassetta E, Binetti G, Tombini M, Del Percio C, Ferreri F, Ferri R, Frisoni G, Lanuzza B, Nobili F, Parisi L, Rodriguez G, Frigerio L, Gurzì M, Prestia A, Vernieri F, Eusebi F, Rossini PM (2007) Resting EEG sources correlate with attentional span in mild cognitive impairment and Alzheimer's disease. Eur J Neurosci 25, 3742-3757. (Pubitemid 47022959)
40. Roh JH, Park MH, Ko D, Park KW, Lee DH, Han C, Jo SA, Yang KS, Jung KY (2011) Region and frequency specific changes of spectral power in Alzheimer's disease and mild cognitive impairment. Clin Neurophysiol 122, 2169-2176.
41. Babiloni C, Binetti G, Cassetta E, Dal Forno G, Del Percio C, Ferreri F, Ferri R, Frisoni G, Hirata K, Lanuzza B, Miniussi C, MorettiDV, Nobili F, Rodriguez G, Romani GL, Salinari S, Rossini PM (2006) Sources of cortical rhythms change as a function of cognitive impairment in pathological aging: A multi-centric study. Clin Neurophysiol 117, 252-268. (Pubitemid 43228015)
42. Farlow M, Anand R, Messina J Jr, Hartman R, Veach J (2000) A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease. Eur Neurol 44, 236-241.
43. Rösler M, Anand R, Cicin-Sain A, Gauthier S, Agid Y, Dal-Bianco P, Stähelin HB, Hartman R, Gharabawi M (1999) Efficacy and safety of rivastigmine in patients with Alzheimer's disease: International randomised controlled trial. BMJ 318, 633-638.
44. Kumar V, Anand R, Messina J, Hartman R, Veach J (2000) An efficacy and safety analysis of Exelon in Alzheimer's disease patients with concurrent vascular risk factors. Eur J Neurol 7, 159-169. (Pubitemid 32260563)
45. Anand R, Hartman R, Sohn H, Danyluk J, Graham SM (2003) Impact of study design and patient population on outcomes from cholinesterase inhibitor trials. Am J Geriatr Psychiatry 11, 160-168. (Pubitemid 36254189)
46. Wilkinson D, Schindler R, Schwam E, Waldemar G, Jones RW, Gauthier S, Lopez OL, Cummings J, Xu Y, Feldman HH (2009) Effectiveness of donepezil in reducing clinical worsening in patients with mild-to-moderate Alzheimer's disease. Dement Geriatr Cogn Disord 28, 244-251.
47. Brassen S, Adler G (2003) Short-term effects of acetylcholinesterase inhibitor treatment on EEG and memory performance in Alzheimer patients: An open, controlled trial. Pharmacopsychiatry 36, 304-308. (Pubitemid 38085149)
48. Onofrj M, Thomas A, Iacono D, Luciano AL, Di Iorio A (2003) The effects of a cholinesterase inhibitor are prominent in patients with fluctuating cognition: A part 3 study of the main mechanism of cholinesterase inhibitors in dementia. Clin Neuropharmacol 26, 239-251. (Pubitemid 37221635)
49. Coben LA, Danziger W, Storandt M (1985) A longitudinal EEG study of mild senile dementia of Alzheimer type: Changes at 1 year and at 2.5 years. Electroencephalogr Clin Neurophysiol 61, 101-112. (Pubitemid 16218363)
50. Soininen H, Partanen J, LaulumaaV, Helkala EL, Laakso M, Riekkinen PJ (1989) Longitudinal EEG spectral analysis in early stage of Alzheimer's disease. Electroencephalogr Clin Neurophysiol 72, 290-297. (Pubitemid 19085665)
51. Jelic V, Johansson SE, Almkvist O, Shigeta M, Julin P, Nordberg A, Winblad B, Wahlund LO (2000) Quantitative electroencephalography in mild cognitive impairment: Longitudinal changes and possible prediction of Alzheimer's disease. Neurobiol Aging 21, 533-540. (Pubitemid 30621491)
52. Jewett DL, Zhang Z (1995) Multiple-generator errors are unavoidable under model misspecification. Electroencephalogr Clin Neurophysiol 95, 135-142.
53. Pascual-Marqui RD, Michel CM (1994) LORETA (low resolution brain electromagnetic tomography): New authentic 3D functional images of the brain. ISBET Newsletter ISSN 5, 4-8.
54. Talairach J, Tournoux P (1988) Co-Planar Stereotaxic Atlas of the Human Brain, Thieme, Stuttgart.
55. Babiloni C, Binetti G, Cassetta E, Cerboneschi D, Dal Forno G, Del Percio C, Ferreri F, Ferri R, Lanuzza B, Miniussi C, Moretti DV, Nobili F, Pascual-Marqui RD, Rodriguez G, Romani GL, Salinari S, Tecchio F, Vitali P, Zanetti O, Zappasodi F, RossiniPM(2004) Mapping distributed sources of cortical rhythms in mild Alzheimer's disease.Amulticentric EEG study. Neuroimage 22, 57-67. (Pubitemid 38515813)
56. Babiloni C, Benussi L, Binetti G, Bosco P, Busonero G, Cesaretti S, Dal Forno G, Del Percio C, Ferri R, Frisoni G, Ghidoni R, Rodriguez G, Squitti R, Rossini PM (2006) Genotype (cystatin C) andEEGphenotype in Alzheimer disease and mild cognitive impairment: A multicentric study. Neuroimage 29, 948-964. (Pubitemid 43121219)
57. Babiloni C, Benussi L, Binetti G, Cassetta E, Dal Forno G, Del Percio C, Ferreri F, Ferri R, Frisoni G, Ghidoni R, Miniussi C, Rodriguez G, Romani GL, Squitti R, Ventriglia MC, Rossini PM (2006) Apolipoprotein E and alpha brain rhythms in mild cognitive impairment: A multicentric EEG study. Ann Neurol 59, 323-334. (Pubitemid 43202486)
58. Babiloni C, Frisoni G, Steriade M, Bresciani L, Binetti G, Del Percio C, Geroldi C, Miniussi C, Nobili F, Rodriguez G, Zappasodi F, Carfagna T, Rossini PM (2006) Frontal white matter volume and delta EEG sources negatively correlate in awake subjects with mild cognitive impairment and Alzheimer's disease. Clin Neurophysiol 117, 1113-1129.
59. Babiloni C, Cassetta E, Dal Forno G, Del Percio C, Ferreri F, Ferri R, Lanuzza B, Miniussi C, Moretti DV, Nobili F, Pascual-Marqui RD, Rodriguez G, Romani LG, Salinari S, Zanetti O, Rossini PM (2006) Donepezil effects on sources of cortical rhythms in mild Alzheimer's disease: Responders vs. non-responders. Neuroimage 31, 1650-1665.
60. Babiloni C, Bosco P, Ghidoni R, Del Percio C, Squitti R, Binetti G, Benussi L, Ferri R, Frisoni G, Lanuzza B, Cassetta E, Anello G, Gurzì M, Bartesaghi S, Lizio R, Tombini M, RossiniPM(2007) Homocysteine and electroencephalographic rhythms in Alzheimer disease: A multicentric study. Neuroscience 145, 942-954. (Pubitemid 46454356)
61. Babiloni C, Bosco P, Ghidoni R, Del Percio C, Squitti R, Binetti G, Benussi L, Ferri R, Frisoni G, Lanuzza B, Cassetta E, Anello G, Gurzi M, Bartesaghi S, Lizio R, Tombini M, RossiniPM(2007) Homocysteine and electroencephalographic rhythms in Alzheimer disease: A multicentric study. Neuroscience 145, 942-954. (Pubitemid 46454356)
62. Babiloni C, Frisoni GB, Pievani M, Toscano L, Del Percio C, Geroldi C, Eusebi F, Miniussi C, Rossini PM (2008) Whitematter vascular lesions correlate with alpha EEG sourcesin mild cognitive impairment. Neuropsychologia 46, 1707-1720.
63. Babiloni C, Frisoni GB, Pievani M, Vecchio F, Infarinato F, Geroldi C, Salinari S, Ferri R, Fracassi C, Eusebi F, Rossini PM (2008) White matter vascular lesions are related to parietal-to-frontal coupling of EEG rhythms in mild cognitive impairment. Hum Brain Mapp 29, 1355-1367.
64. Babiloni C, Frisoni G, Pievani M, Vecchio F, Lizio R, Buttiglione M, Geroldi C, Fracassi C, Eusebi F, Ferri R, Rossini PM (2009) Hippocampal volume and cortical sources of EEG alpha rhythms in mild cognitive impairment and Alzheimer disease. Neuroimage 44, 123-135.
65. Babiloni C, Pievani M, Vecchio F, Geroldi C, Eusebi F, Fracassi C, Fletcher E, De Carli C, Boccardi M, Rossini PM, Frisoni GB (2009) White-matter lesions along the cholinergic tracts are related to cortical sources of EEG rhythms in amnesic mild cognitive impairment. Hum Brain Mapp 30, 1431-1443.
66. Babiloni C, Visser PJ, Frisoni G, De Deyn PP, Bresciani L, Jelic V, Nagels G, Rodriguez G, Rossini PM, Vecchio F, Colombo D, Verhey F, Wahlund LO, Nobili F (2010) Cortical sources of resting EEG rhythms in mild cognitive impairment and subjective memory complaint. Neurobiol Aging 31, 1787-1798.
67. Babiloni C, Frisoni GB, Vecchio F, Pievani M, Geroldi C, De Carli C, Ferri R, Vernieri F, Lizio R, Rossini PM (2010) Global functional coupling of restingEEGrhythms is related to white-matter lesions along the cholinergic tracts in subjects with amnesic mild cognitive impairment. J Alzheimers Dis 19, 859-871.
68. Babiloni C, Lizio R, Carducci F, Vecchio F, Redolfi A, Marino S, Tedeschi G, Montella P, Guizzaro A, Esposito F, Bozzao A, Giubilei F, Orzi F, Quattrocchi CC, Soricelli A, Salvatore E, Baglieri A, Bramanti P, Cavedo E, Ferri R, Cosentino F, Ferrara M, Mundi C, Grilli G, Pugliese S, Gerardi G, Parisi L, Vernieri F, Triggiani AI, Pedersen JT, Hårdemark HG, Rossini PM, Frisoni GB (2011) Resting state cortical electroencephalographic rhythms and white matter vascular lesions in subjects with Alzheimer's disease: An Italian multicenter study. J Alzheimers Dis 26, 331-346.
69. Babiloni C, De Pandis MF, Vecchio F, Buffo P, Sorpresi F, Frisoni GB, Rossini PM (2011) Cortical sources of resting state electroencephalographic rhythms in Parkinson's disease related dementia and Alzheimer's disease. Clin Neurophysiol 122, 2355-2364.
70. Babiloni C, Frisoni GB, Vecchio F, Lizio R, Pievani M, Geroldi C, Fracassi C, Vernieri F, Rodriguez G, Nobili F, Ferri R, Rossini PM (2011) Stability of clinical condition in mild cognitive impairment is related to cortical sources of alpha rhythms: An electroencephalographic study. Hum Brain Mapp 32, 1916-1931.
71. Babiloni C, Carducci F, Lizio R, Vecchio F, Baglieri A, Bernardini S, Cavedo E, Bozzao A, Buttinelli C, Esposito F, Giubilei F, Guizzaro A, Marino S, Montella P, Quattrocchi CC, Redolfi A, Soricelli A, Tedeschi G, Ferri R, Rossi-Fedele G, Ursini F, Scrascia F, Vernieri F, Pedersen TJ, Hardemark HG, Rossini PM, Frisoni GB (2012) Resting state cortical electroencephalographic rhythms are related to gray matter volume in subjects with mild cognitive impairment and Alzheimer's disease. Hum Brain Mapp 2012 Feb 14.
72. Gianotti LR, Künig G, Lehmann D, Faber PL, Pascual- Marqui RD, Kochi K, Schreiter-Gasser U (2007) Correlation between disease severity and brain electric LORETA tomography in Alzheimer's disease. Clin Neurophysiol 118, 186-196. (Pubitemid 44960935)
73. Folstein MF, Folstein SE, McHugh PR (1975) Mini Mental State': A practical method for grading the cognitive state of patients for clinician. J Psychiatr Res 12, 189-198.
74. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34, 939-944. (Pubitemid 14076461)
75. Hughes CP, Berg L, Danziger WL, Cohen LA, Martin RL (1982) A new clinical rating scale for the staging of dementia. Br J Psychiatry 140, 1225-1230.
76. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer VO (1982-83) Development and validation of a geriatric depression screening scale: A preliminary report. J Psychiatr Res 17, 37-49. (Pubitemid 13123113)
77. Rosen WG, Terry RD, Fuld PA, Katzman R, Peck A (1980) Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 7, 486-488. (Pubitemid 10073130)
78. Lawton MP, Brodie EM (1969) Assessment of older people: Self maintaining and instrumental activity of daily living. J Gerontol 9, 179-186.
79. Buchan RJ, Nagata K, Yokoyama E, Langman P, Yuya H, Hirata Y, Hatazawa J, Kanno I (1997) Regional correlations between the EEG and oxygen metabolism in dementia of Alzheimer's type. Electroencephalogr Clin Neurophysiol 103, 409-417. (Pubitemid 27382152)
80. Pucci E, Belardinelli N, Cacchio G, Signorino M, Angeleri F (1999) EEG power spectrum differences in early and late onset forms of Alzheimer's disease. Clin Neurophysiol 110, 621-631. (Pubitemid 29236388)
81. Rodriguez G,Vitali P, De Leo C, De Carli F, Girtler N, Nobili F (2002) Quantitative EEG changes in Alzheimer patients during long-term donepezil therapy. Neuropsychobiology 46, 49-56. (Pubitemid 35002318)
82. Szelies B, MielkeR,Kessler J, HeissWD(1999)EEGpower changes are related to regional cerebral glucose metabolism in vascular dementia. Clin Neurophysiol 110, 615-620. (Pubitemid 29236387)
83. Moretti DV, Babiloni F, Carducci F, Cincotti F, Remondini E, Rossini PM, Salinari S, Babiloni C (2003) Computerized processing of EEG-EOG-EMG artifacts for multicentirc studies in EEG oscillations and event-related potentials. Int J Psychophysiol 47, 199-216. (Pubitemid 36344134)
84. Besthorn C, Zerfass R, Geiger-Kabisch C, Sattel H, Daniel S, Schreiter-Gasser U, Forstl H (1997) Discrimination of Alzheimer's disease and normal aging by EEG data. Electroencephalogr Clin Neurophysiol 103, 241-248. (Pubitemid 27351619)
85. Chiaramonti R, Muscas GC, Paganini M, Muller TJ, Fallgatter AJ, Versari A, Strik WK (1997) Correlations of topographical EEG features with clinical severity in mild and moderate dementia of Alzheimer type. Neuropsychobiology 36, 153-158. (Pubitemid 27384830)
86. JelicV, Shigeta M, Julin P, Almkvist O,Winblad B, Whalund LO (1996) Quantitative electroencephalography power and coherence in Alzheimer's disease and mild cognitive impairment. Dementia 7, 314-323. (Pubitemid 26341260)
87. Leuchter AF, Cook IA, Newton TF, Dunkin J, Walter DO, Rosenberg Tompson S, Lachenbruch PA, Weiner H (1993) Regional differences in brain electrical activity in dementia: Use of spectral power and spectral ratio measures. Electroenceph Clin Neurophysiol 87, 385-393. (Pubitemid 24012334)
88. Rodriguez G, Copello F, Nobili F, Vitali P, Perego G, Nobili F (1999) EEG spectral profile to stage Alzheimer's disease. Clin Neurophysiol 110, 1831-1837. (Pubitemid 29459161)
89. Holschneider DP, Waite JJ, Leuchter AF, Walton NY, Scremin OU (1999) Changes in electrocortical power and coherence in response to the selective cholinergic immunotoxin 192 IgG-saporin. Exp Brain Res 126, 270-280. (Pubitemid 29219105)
90. Kolev V, Yordanova J, Basar-Eroglu C, Basar E (2002) Age effects on visual EEG responses reveal distinct frontal alpha networks. Clin Neurophysiol 113, 901-910. (Pubitemid 34621196)
91. Nobili F, Taddei G, Vitali P, Bazzano L, Catsafados E, Mariani G, Rodriguez G (1998) Relationships between 99m Tc-HMPAO ceraspect and quantitative EEG observations in Alzheimer's disease. Arch Gerontol Geriatr 6, 363-368.
92. Pucci E, Cacchiò G, Angeloni R, Belardinelli N, Nolfe G, Signorino M (1997) Angeleri F EEG spectral analysis Alzheimer's disease and different degenerative dementias. Arch Gerontol Geriatr 26, 283-297.
93. Klimesch W (1996) Memory processes, brain oscillations and EEG synchronization. Int J Psychophysiol 24, 61-100. (Pubitemid 27013763)
94. Klimesch W, Doppelmayr M, Pachinger T, Russegger H (1997) Event-related desynchronization in the alpha band and the processing of semantic information. Brain Res Cogn Brain Res 6, 83-94. (Pubitemid 28010031)
95. Klimesch W, Doppelmayr M, Russegger H, Pachinger T, Schwaiger J (1998) Induced alpha band power changes in the human EEG and attention. Neurosci Lett 244, 73-76. (Pubitemid 28157394)
96. Szava S, Valdes P, Biscay R, Galan L, Bosch J, Clark I, Jimenez JC (1994) High resolution quantitative EEG analysis. Brain Topogr 6, 211-219. (Pubitemid 24127778)
97. Pascual-Marqui RD, Lehmann D, Koenig T, Kochi K, Merlo MC, Hell D, Koukkou M (1999) Low resolution brain electromagnetic tomography (LORETA) functional imaging in acute, neuroleptic-naive, firstepisode, productive schizophrenia. Psychiatry Res 90, 169-179. (Pubitemid 29349649)
98. Pascual-Marqui RD, Esslen M,Kochi K, LehmannD(2002) Functional imaging with low resolution brain electromagnetic tomography (LORETA): A review. Methods Find Exp Clin Pharmacol 24, 91-95. (Pubitemid 35447387)
99. Yao D, He B (2001) A self-coherence enhancement algorithm and its application to enhancing three-dimensional source estimation from EEGs. Ann Biomed Eng 29, 1019-1027. (Pubitemid 34055203)
100. Anderer P, Saletu B, Semlitsch HV, Pascual-Marqui RD (2003) Noninvasive localization of P300 sources in normal aging and ageassociated memory impairment. Neurobiol Aging 24, 463-479. (Pubitemid 36205052)
101. Anderer P, Saletu B, Saletu-Zyhlarz G, Gruber D, Metka M, Huber J, Pascual-Marqui RD (2004) Brain regions activated during an auditory discrimination task in insomniac postmenopausal patients before and after hormone replacement therapy: Low-resolution brain electromagnetic tomography applied to event-related potentials. Neuropsychobiology 49, 134-153. (Pubitemid 38420851)
102. Laufer I, Pratt H (2003) Evoked potentials to auditory move ment sensation in duplex perception. Clin Neurophysiol 114, 1316-1331. (Pubitemid 36776831)
103. Mulert C, Gallinat J, Pascual-Marqui R, Dorn H, Frick K, Schlattmann P, Mientus S, Herrmann WM, Winterer G (2001) Reduced event-related current density in the anterior cingulate cortex in schizophrenia. Neuroimage 13, 589-600. (Pubitemid 34184982)
104. Talairach J, Tournoux P (1988) Co-Planar Stereotaxic Atlas of the Human Brain. Stuttgart: Thieme. AQ4.
105. Nuwer MR (1988) Quantitative EEG. I: Techniques and problems of frequency analysis and topographic mapping. J Clin Neurophysiol 5, 1-43. (Pubitemid 18045956)
106. Hernández JL, Valdés P, Biscay R, Virues T, Szava S, Bosch J, Riquenes A, Clark I (1994) A global scale factor in brain topography. Int J Neurosci 76, 267-278. (Pubitemid 2116146)
107. Rossini PM, Del Percio C, Pasqualetti P, Cassetta E, Binetti G, Dal Forno F, Ferreri F, Frisoni G, Chiovenda P, Miniussi C, Parisi L, Tombini M, Vecchio F, Babiloni C (2006) Conversion from mild cognitive impairment to Alzheimer's disease is predicted by sources and coherence of brain electroencephalography rhythms. Neuroscience 143, 793-803. (Pubitemid 44781284)
108. Steriade M (2003) Cerebello-cerebral interactions during states of vigilance. Cerebellum 2, 82-83. (Pubitemid 38282189)
109. Gloor P, Ball G, Schaul N (1977) Brain lesions that produce delta waves in the EEG. Neurology 27, 326-333. (Pubitemid 8200087)
110. D'Amelio M, RossiniPM(2012) Brain excitability and connectivity of neuronal assemblies in Alzheimer's disease: From animal models to human findings. Prog Neurobiol 99, 42-60.
111. Pfurtscheller G, Lopez da Silva F (1999) Event-related EEG/MEG synchronization and desynchronization: Basic principles. Clin Neurophysiol 110, 1842-1857. (Pubitemid 29454610)
112. Hughes SW, Crunelli V (2005) Thalamic mechanisms of EEG alpha rhythms and their pathological implications. Neuroscientist 11, 357-372. (Pubitemid 41040864)
113. Lorincz ML, Kékesi KA, Juhász G, Crunelli V, Hughes SW (2009) Temporal framing of thalamic relay-mode firing by phasic inhibition during the alpha rhythm. Neuron 63, 683-696.
114. Capizzano AA, Ación L, Bekinschtein T, Furman M, Gomila H, Martínez A, Mizrahi R, Starkstein SE (2004) White matter hyperintensities are significantly associated with cortical atrophy in Alzheimer's disease. J Neurol Neurosurg Psychiatry 75, 822-827. (Pubitemid 38658501)
115. Gootjes L, Teipel SJ, Zebuhr Y, Schwarz R, Leinsinger G, Scheltens P,Möller HJ, Hampel H (2004) Regional distribution of white matter hyperintensities in vascular dementia, Alzheimer's disease and healthy aging. Dement Geriatr Cogn Disord 18, 180-188. (Pubitemid 39140369)
116. Tullberg M, Fletcher E, DeCarli C, Mungas D, Reed BR, Harvey DJ,WeinerMW, Chui HC, Jagust WJ (2004) White matter lesions impair frontal lobe function regardless of their location. Neurology 63, 246-253. (Pubitemid 38971122)